CN101979032A - Medicament for treating calcaneus spur hyperplasia - Google Patents

Medicament for treating calcaneus spur hyperplasia Download PDF

Info

Publication number
CN101979032A
CN101979032A CN2010105257038A CN201010525703A CN101979032A CN 101979032 A CN101979032 A CN 101979032A CN 2010105257038 A CN2010105257038 A CN 2010105257038A CN 201010525703 A CN201010525703 A CN 201010525703A CN 101979032 A CN101979032 A CN 101979032A
Authority
CN
China
Prior art keywords
parts
medicament
medicine
treatment
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105257038A
Other languages
Chinese (zh)
Inventor
赵仁顺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zuoquan County Lantian Tcm Technology Development Co Ltd
Original Assignee
Zuoquan County Lantian Tcm Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zuoquan County Lantian Tcm Technology Development Co Ltd filed Critical Zuoquan County Lantian Tcm Technology Development Co Ltd
Priority to CN2010105257038A priority Critical patent/CN101979032A/en
Publication of CN101979032A publication Critical patent/CN101979032A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament, in particular to a medicament for treating calcaneus spur hyperplasia. The medicament solves the treatment problem of the calcaneus spur hyperplasia. The Chinese medicament is prepared from the following medicaments in part by weight: 40 to 50 parts of long-noded pit viper, 30 to 40 parts of garden balsam stem, 70 to 75 parts of clematis root, 35 to 40 parts of Chinese angelica, 30 to 36 parts of divaricate saposhnikovia root, 35 to 40 parts of ground beetle and 30 to 40 parts of dragon's blood. The medicaments are baked and ground into fine powder, and the fine powder is mixed to form the Chinese medicament. The medicament can treat the calcaneus spur hyperplasia caused by various reasons.

Description

The outgrowth medicine of treatment calcanean spur
Technical field
The present invention relates to a kind of Chinese medicine, be specially the outgrowth medicine of a kind of treatment calcanean spur.
Background technology
Heel bone hyperosteogeny has another name called calcanean spur, talalgia.Calcanean spur is a commonly encountered diseases clinically, frequently-occurring disease it, be common in middle-aged and elderly people, main performance has heel portion pain, its pain is how relevant with long plantar ligament and contracture of plantar fascia.The pain increased after pressure increased the weight of during walking along the street; Because of local pain, heel dare not land during walking along the street, and phenomenon is on tiptoe arranged; When heel portion presses with thumb, tenderness is arranged sometimes.Primary disease is many to lose void by kidney qi, asthenia of essence and blood, and cold and stagnate, wind-damp numbness forms.Its pathogeny is that the mistake of muscle arteries and veins is supported, and contracture is not stretched, stagnation of QI and blood may bring about pain.The arthromyodynia category that belongs to Chinese medicine.This disease can be by taking medicine, and the drug of topical application or the way of performing an operation are treated.
Summary of the invention
The present invention provides a kind of treatment calcanean spur outgrowth medicine in order to solve the outgrowth treatment problem of calcanean spur.
The present invention is realized by following technical scheme, the outgrowth medicine of a kind of treatment calcanean spur is made up of the medicine of following weight ratio example: Agkistrodon 40-50 part, Herba speranskiae tuberculatae 30-40 part, Radix Clematidis 70-75 part, Radix Angelicae Sinensis 35-40 part, Radix Saposhnikoviae 30-36 part, Eupolyphaga Seu Steleophaga 35-40 part, Sanguis Draxonis 30-40 part.Above medicine dries, and grinds to fine powder mixes, and gets final product.
Agkistrodon is sweet, salty, temperature; Poisonous.Return Liver Channel.Dispel the wind collateral dredging, relieving convulsion.Be used for rheumatoid arthritis stubborn, numbness contracture, middle air port is askew, hemiplegia, tic spasm, tetanus, leprosy scabies, scrofula malignant boil; The Herba speranskiae tuberculatae expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation and stopping pain is separated and is poisoned rash; Radix Clematidis cures mainly gout insensitive impediment, rheumatic arthralgia, numb limbs and tense tendons, chills and pain of the waist and kness, the contracture of muscle arteries and veins, joint stuffiness, beriberi, malaria, lump in the abdomen, tetanus, tonsillitis, all a fishbone or other bone caught in the throat pharynxs; Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Be used for blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores; Radix Saposhnikoviae is delivered, and dispels the wind, and wins and wets, pain relieving.Control affection of exogenous wind-cold, headache, dizzy, stiffness of the nape, anemofrigid-damp arthralgia, joint is ached, and the extremity contraction is anxious, tetanus.Eupolyphaga Seu Steleophaga removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones.Be used for the muscles and bones folding and hinder blood stasis amenorrhea, lump in the abdomen mass in the abdomen.Sanguis Draxonis, the effect promoting blood circulation to remove blood stasis, analgesic therapy, hemostasia and promoting granulation is held back skin ulcer.Cure mainly and control treating swelling and pain by traumatic injury, ecchymoma due to internal injury; Continuous bleeding due to traumatic injury, scrofula, ecthyma unhealed for long time.
Clinical treatment briefing: treat about 210 examples of local patient over several years altogether, male 150 examples, women 60 examples, minimum 42 years old of age, maximum 73 years old.Main diagnosis basis: (1) patient when standing and walk, heel pain, rise particularly evident morning, after the short time walking, the side has and alleviates; (2) look into the bilateral heel, can touch the bone projection at Ipsilateral calcaneus origin of force, and irritated tenderness is arranged; (4) knot shape thing appears in the subcutaneous tissue around the part patient bony spur; (5) X-ray film can show, the calcaneus origin of force has hyperosteogeny.
Therapeutic Method: get Agkistrodon 45 grams, Herba speranskiae tuberculatae 35 grams, Radix Clematidis 72 grams, Radix Angelicae Sinensis 36 grams, Radix Saposhnikoviae 34 grams, Eupolyphaga Seu Steleophaga 37 grams, Sanguis Draxonis 36 grams.Above medicine dries, and grinds to fine powder mixes, and is divided into 50 parts then, adorns a bag for every part.The mode of taking is oral, and once a day, each 5 parts was a course of treatment with 15 days.
Therapeutic outcome: criterion of therapeutical effect recovery from illness: heel pain disappears, activity freely, the normal person of functional rehabilitation; Produce effects: heel pain obviously alleviates, and activity is the person substantially freely; Take a turn for the better: heel pain alleviates, and is movable than the forward step person; Invalid: symptom and sign does not have significant change person.
Table 1 therapeutic outcome statistics
Group The example number Recovery from illness Produce effects Take a turn for the better Invalid Cure rate % Effective percentage %
The man 150 120 28 2 7 80 95
The woman 60 47 11 2 3 79 95
The situation statistics of table 2 course of disease and curative effect
210 examples Recovery from illness Produce effects Take a turn for the better Invalid
In 2 years 90 75 8 3 4
More than 2 years 120 92 31 1 6
Table 3 course of treatment and curative effect situation statistics
Recovery from illness Produce effects Take a turn for the better Invalid
1 course of treatment 63 18 2 3
2 courses of treatment 55 12 1 3
3 and the above course of treatment 49 9 1 4
Analysis-by-synthesis, the total effective rate of treatment reaches more than 95%.
Model case
1, Zhang, people from Jinzhong City, Shanxi Province, the man, 55 years old, the workman of power plant felt away the stretch rear foot with regard to feels pain during calendar year 2001, confirmed as heel bone hyperosteogeny through checking, take this medicine after two courses of treatment symptom disappear substantially, no longer do not feel like oneself on foot.
2, Guo, Shanxi province Taiyuan city people, the woman, 60 years old, the retired cadre suffers from the heel bone hyperosteogeny several years, and was handicapped, controlled for a long time to lose positive effect, took this medicine after three courses of treatment, and symptom obviously alleviates, and walks freely, does not have obstacle.
3, Zhao, people from Yushe County, Shanxi Province, man, 59 years old, machine-operated worker, in JIUYUE, 2006 comes this place to go to a doctor, and after the morbidity, does not treat then, and the state of an illness increases the weight of after six months, to such an extent as to pain can't be walked, liniment treatment loses positive effect, after through taking medicine after three courses of treatment, symptom disappears substantially.
4, appoint certain, the man, 47 years old, the mine worker suffered from heel bone hyperosteogeny because of long-term particular job environment, and the difficulty of walking has had a strong impact on work, and multiple medical way loses effect, and this medicine transference cure after course of treatment is taken in this punishment treatment over 2007 then.
5, Wang, man, 50 years old, driver, suffer from lighter heel bone hyperosteogeny for many years, do not influence driving, but walk still feels pain, paste external medication and lose positive effect, took this medicine after two months courses of treatment in this punishment treatment in 2003, symptom disappears substantially.
The specific embodiment
Embodiment 1, the outgrowth medicine of a kind of treatment calcanean spur are made up of the medicine of following weight ratio example: Agkistrodon 40 grams, Herba speranskiae tuberculatae 40 grams, Radix Clematidis 70 grams, Radix Angelicae Sinensis 40 grams, Radix Saposhnikoviae 30 grams, Eupolyphaga Seu Steleophaga 40 grams, Sanguis Draxonis 30 grams.Above medicine dries, and grinds to fine powder mixes, and is divided into 60 parts then, adorns a bag for every part.Also can be processed as pill, capsule.
Embodiment 2, the outgrowth medicine of a kind of treatment calcanean spur are made up of the medicine of following weight ratio example: 50 parts of Agkistrodons, 40 parts of 35 parts of Sanguis Draxonis of 36 parts of Eupolyphaga Seu Steleophagas of 35 parts of Radix Saposhnikoviaes of 75 parts of Radix Angelicae Sinensis of 30 parts of Radix Clematidis of Herba speranskiae tuberculatae.Above medicine dries, and grinds to fine powder mixes, and is divided into 40 parts then, adorns a bag for every part.Also can be processed as pill, capsule.
Embodiment 3, the outgrowth medicine of a kind of treatment calcanean spur are made up of the medicine of following weight ratio example: 45 parts of Agkistrodons, 36 parts of 37 parts of Sanguis Draxonis of 34 parts of Eupolyphaga Seu Steleophagas of 36 parts of Radix Saposhnikoviaes of 72 parts of Radix Angelicae Sinensis of 35 parts of Radix Clematidis of Herba speranskiae tuberculatae.Above medicine dries, and grinds to fine powder mixes, and is divided into 50 parts then, adorns a bag for every part.Also can be processed as pill, capsule.

Claims (2)

1. the outgrowth medicine of treatment calcanean spur is characterized in that being made up of the medicine of following weight ratio example: Agkistrodon 40-50 part, Herba speranskiae tuberculatae 30-40 part, Radix Clematidis 70-75 part, Radix Angelicae Sinensis 35-40 part, Radix Saposhnikoviae 30-36 part, Eupolyphaga Seu Steleophaga 35-40 part, Sanguis Draxonis 30-40 part.
2. the outgrowth medicine of treatment calcanean spur according to claim 1 is characterized in that being made up of the medicine of following weight ratio example: 45 parts of Agkistrodons, 35 parts of Herba speranskiae tuberculataes, 72 parts of Radix Clematidis, 36 parts of Radix Angelicae Sinensis, 34 parts of Radix Saposhnikoviaes, 37 parts of Eupolyphaga Seu Steleophagas, 36 parts of Sanguis Draxonis.
CN2010105257038A 2010-10-26 2010-10-26 Medicament for treating calcaneus spur hyperplasia Pending CN101979032A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105257038A CN101979032A (en) 2010-10-26 2010-10-26 Medicament for treating calcaneus spur hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105257038A CN101979032A (en) 2010-10-26 2010-10-26 Medicament for treating calcaneus spur hyperplasia

Publications (1)

Publication Number Publication Date
CN101979032A true CN101979032A (en) 2011-02-23

Family

ID=43599587

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105257038A Pending CN101979032A (en) 2010-10-26 2010-10-26 Medicament for treating calcaneus spur hyperplasia

Country Status (1)

Country Link
CN (1) CN101979032A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104288434A (en) * 2014-09-18 2015-01-21 罗小平 Internal medicine for treating lumbar disc herniation
CN104906255A (en) * 2015-06-10 2015-09-16 孔令刚 Traditional Chinese medicine for treating calcanean spur
CN113648362A (en) * 2021-08-17 2021-11-16 郑小春 Traditional Chinese medicine for treating cervical spondylosis and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1406600A (en) * 2001-08-22 2003-04-02 胡克岗 Medicine for hyperosteogeny

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1406600A (en) * 2001-08-22 2003-04-02 胡克岗 Medicine for hyperosteogeny

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《中医杂志》 19811231 丁少坡 骨质增生验方 56 1-2 , 第04期 2 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104288434A (en) * 2014-09-18 2015-01-21 罗小平 Internal medicine for treating lumbar disc herniation
CN104906255A (en) * 2015-06-10 2015-09-16 孔令刚 Traditional Chinese medicine for treating calcanean spur
CN113648362A (en) * 2021-08-17 2021-11-16 郑小春 Traditional Chinese medicine for treating cervical spondylosis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103961636B (en) Orthopedic disease treatment external application traditional Chinese medicine composition, preparation method and application thereof
CN104189871A (en) Medicated wine for treating osteoproliferation
CN104258278B (en) Gushangling (for bone injury) spray
CN102008610A (en) Traditional Chinese medicine composition for curing hyperosteogeny
CN102895601A (en) Medicament for treating neck-shoulder pain
CN101979032A (en) Medicament for treating calcaneus spur hyperplasia
CN101843676B (en) Chinese medicinal preparation for treating varicosity diseases and preparation method thereof
CN101721651B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN105106796A (en) Traditional Chinese medicine composition for treating fracture and preparation method of traditional Chinese medicine composition
CN103100017B (en) Traditional Chinese medicine health care product for relieving muscle and bone pain and arthralgia and preparation method thereof
CN102824470B (en) Medicinal liquor for treating proplapse of lumbar intervertebral disc, ischialgia and leg pain
CN102274372B (en) Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage
CN104840656B (en) A kind of nursing medicine for the treatment of de Quervain's disease
CN101194985B (en) Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny
CN105412626A (en) Medicine preparation for treating cervical spine bone hyperplasia and application of medicine preparation
CN101195002B (en) Chinese medicine emplastrum for releasing ache and health care
CN104258285A (en) Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof
CN1228064C (en) Externally appied medicine for relieving pain and diminishing inflammation
CN109966451A (en) A kind of Chinese medicine composition of bone-setting and pain-relieving
CN102204966B (en) Traditional Chinese medicine liniment for external use for relaxing muscles and tendons and alleviating pain
CN102846684B (en) Medicament for treating bony spurs
CN101204436B (en) Chinese patent medicine for curing hyperosteogeny in knee joint
CN102205102B (en) Chinese medical plantar pain-relieving ointment for treating plantar fasciitis
CN1899564A (en) External use medicine for treating hyperosteogeny and protrusion of intervertebral disc
CN1406600A (en) Medicine for hyperosteogeny

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20110223